Mental health conditions and receipt of mental health care by illicit lysergic acid diethylamide (LSD) use status among young adults in the United States

Aim To examine prevalence of mental health conditions and receipt of mental health care (MHC) by illicit lysergic acid diethylamide (LSD) use status (past‐year; lifetime without‐past‐year; never) among young adults. Design Cross‐sectional, annual survey data from 2015 to 2019 National Surveys on Dru...

Full description

Saved in:
Bibliographic Details
Published in:Addiction (Abingdon, England) England), 2022-06, Vol.117 (6), p.1794-1800
Main Authors: Han, Beth, Blanco, Carlos, Einstein, Emily B., Compton, Wilson M.
Format: Article
Language:English
Subjects:
Acids
Adolescent
Adult
any mental illness
Clinical outcomes
Cross-Sectional Studies
Depressive Disorder, Major - complications
Depressive Disorder, Major - epidemiology
Diagnostic and Statistical Manual
Drug abuse
Drugs
Hallucinogens
Health care
Humans
illicit lysergic acid diethylamide (LSD) use
Illnesses
Inpatient care
LSD
Lysergic Acid Diethylamide
Lysergide
major depressive episode
Mental depression
Mental disorders
Mental Disorders - complications
Mental Disorders - epidemiology
Mental Health
Mental health care
mental health conditions
Mental health services
Polls & surveys
Prescription Drugs
Prevention programs
Psychological distress
receipt of mental health care
serious mental illness
serious psychological distress
Substance-Related Disorders - complications
Substance-Related Disorders - epidemiology
Substance-Related Disorders - therapy
Suicidal behavior
Suicidal ideation
Suicide
United States - epidemiology
Young Adult
Young adults
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim To examine prevalence of mental health conditions and receipt of mental health care (MHC) by illicit lysergic acid diethylamide (LSD) use status (past‐year; lifetime without‐past‐year; never) among young adults. Design Cross‐sectional, annual survey data from 2015 to 2019 National Surveys on Drug Use and Health (NSDUH). Setting United States. Participants A total of 69 916 NSDUH participants ages 18 to 25. Measurements Outcomes included past‐year serious psychological distress (SPD), suicidal ideation, Diagnostic and Statistical Manual of Mental Disorders (DSM)‐IV major depressive episode (MDE), any mental illness, serious mental illness, receipt of mental health care (MHC, inpatient/outpatient or receipt of prescription medications), and number of days of being unable to work or attend normal activities because of mental health conditions. Findings Multivariable analyses found that compared with those who never used illicit LSD, adults with past‐year illicit LSD use had greater risk of suicidal ideation (adjusted risk ratio [ARR] = 1.2, 95% CI = 1.06–1.41), SPD (ARR = 1.2, 95% CI = 1.04–1.28), MDE (ARR = 1.3, 95% CI = 1.17–1.52), and any/serious mental illness (ARRs = 1.2–1.3, 95% CI = 1.02–1.41) and reported missing more days because of mental health conditions (adjusted incidence rate ratio = 1.6, 95% CI = 1.31–1.86). Lifetime (without past‐year) use showed similar, although less consistent, associations. Compared with those never using illicit LSD, adults with past‐year use were less likely to receive prescription medications for MHC (ARR = 0.7, 95% CI = 0.60–0.84) and to receive overall MHC (ARR = 0.7, 95% CI= 0.64–0.84). Compared with those using in the past‐year, adults with lifetime (without past‐year) use were more likely to receive prescription medications for MHC (ARR = 1.2, 95% CI = 1.01–1.46) and receive overall MHC (ARR = 1.2, 95% CI = 1.03–1.45). Conclusions Young adults with past‐year illicit lysergic acid diethylamide use have elevated prevalence of mental health conditions and are less likely to receive prescription medications for mental health care and overall mental health care. Regardless of past‐year use status, young adults with lifetime illicit lysergic acid diethylamide use may benefit from mental illness prevention and interventions.
ISSN:0965-2140
1360-0443
DOI:10.1111/add.15789